6 Einträge gefunden

1. MUC1 (CA27.29) before and after Chemotherapy and Prognosis in High-Risk Early Breast Cancer Patients

   1. Huebner, Hanna
   2. Häberle, Lothar
   3. Müller, Volkmar
   4. Schrader, Iris
   5. Lorenz, Ralf
   6. Forstbauer, Helmut
   7. Fink, Visnja

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer-results from the randomized phase III SUCCESS-A trial

   1. de Gregorio, Amelie
   2. Häberle, Lothar
   3. Fasching, Peter A
   4. Müller, Volkmar
   5. Schrader, Iris
   6. Lorenz, Ralf
   7. Forstbauer, Helmut

   2020 - Forschungsinformationssystem des UKE
3. A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial

   1. Karn, Thomas
   2. Meissner, Tobias
   3. Weber, Karsten E
   4. Solbach, Christine
   5. Denkert, Carsten
   6. Engels, Knut
   7. Fasching, Peter A

   2020 - Forschungsinformationssystem des UKE
4. Prognostic impact of circulating tumor cells for breast cancer patients treated in the neoadjuvant "Geparquattro" trial

   1. Riethdorf, Sabine
   2. Müller, Volkmar
   3. Loibl, Sibylle
   4. Nekljudova, Valentina
   5. Weber, Karsten E
   6. Huober, Jens
   7. Fehm, Tanja

   2017 - Forschungsinformationssystem des UKE
5. HER2 Dimerization Inhibitor Pertuzumab - Mode of Action and Clinical Data in Breast Cancer

   1. Harbeck, Nadia
   2. Beckmann, Matthias W
   3. Rody, Achim
   4. Schneeweiss, Andreas
   5. Müller, Volkmar
   6. Fehm, Tanja
   7. Marschner, Norbert

   2013 - Forschungsinformationssystem des UKE
6. Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial.

   1. Riethdorf, Sabine
   2. Müller, Volkmar
   3. Zhang, Liling
   4. Rau, Thomas
   5. Loibl, Sibylle
   6. Komor, Martina
   7. Roller, Marc

   2010 - Forschungsinformationssystem des UKE